Open access
Oct 2026
Understanding competing mortality in patients with early-stage ER+ breast cancer.
217 Background: Long-term endocrine therapy reduces recurrence in early-stage hormone receptor-positive breast cancer (BC) but may worsen comorbidities and survival. Understanding competing causes of mortality is essential for individualized treatment. We characterized cause-specific mortality and risk factor p...
C. Wabl, Morah Brown, Shi-Yun Zhu et al.
· JCO Oncology Practice · 0 citations